Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
After an undergraduate degree at Cambridge University, Nick Holliday obtained his PhD at King’s College London, supported by an AJ Clark PhD studentship from the British Pharmacological Society.
I am currently Vice President and Global Medicine Leader at AstraZeneca where I lead life-cycle development of Lynparza (Olaparib; PARP inhibitor), which is licenced globally for treatment of ovarian, breast, pancreatic and prostate cancers.
Peter Holzer is Professor of Experimental Neurogastroenterology at the Institute of Experimental and Clinical Pharmacology of the Medical University of Graz in Austria and Dean of Doctoral Studies.
Dr Htet is a senior lecturer/head of department at the Department of Pharmacology and Therapeutics, School of Medicine, International Medical University (IMU), Malaysia.
Yu Huang was awarded BSc by Fudan University Shanghai Medical College and PhD in Pharmacology by University of Cambridge.
Dyfrig graduated in pharmacy at Cardiff University before undertaking a PhD in cardiovascular pharmacology at the University of Liverpool.
My main employment was with the Department of Pharmacology, University of Leeds with significant periods in Australia, Guyana, Kuwait, Saudi Arabia and Egypt.
Laura Humphrys is a researcher interested in all things surrounding G protein coupled receptor (GPCR) pharmacology, particularly in the translation between structure to biochemistry to (patho)physiology.